非常规 T 细胞在泌尿系统肿瘤中:能抓住就抓住
Unconventional T cells in urological cancers: catch them if you can.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
放射和卡介苗(BCG)灌注在临床上用于治疗尿路上皮癌,但其激活免疫反应的确切机制仍不清楚。cGAS-STING通路的作用已在BCG和辐射诱导的免疫反应中有所涉及;然而,尚未对尿路上皮癌治疗后STING通路分子和免疫景观进行比较。
因此,我们在一个成熟的自发性小鼠尿路上皮癌模型中,全面分析了放疗和BCG灌注后膀胱肿瘤微环境中的局部免疫反应,以深入了解STING介导的免疫反应的激活。小鼠在治疗前暴露于口服致癌物BBN 12周,随后接受单次15 Gy剂量的放疗或三次膀胱内BCG灌注(1 × 10 8 CFU)。处死时,由泌尿病理学家对肿瘤进行分期,并使用NanoString髓系先天免疫Panel和免疫组织化学测量治疗对免疫微环境的影响。通过在由BCG治疗的非肌层浸润性尿路上皮癌组成的人组织微阵列上测量cGAS和STING的免疫生物标志物表达,确立了临床相关性。小鼠模型中的BCG灌注提高了STING及下游STING诱导的干扰素和促炎分子、瘤内M1巨噬细胞和T细胞积聚,并实现完全肿瘤根除。相比之下,放疗未引起STING通路或先天免疫基因表达的变化;相反,它诱导了M2巨噬细胞积聚和FoxP3表达升高,这是免疫抑制的特征。在人类非肌层浸润性膀胱癌中,对 BCG 治疗有应答的患者基线 STING 蛋白表达升高,并且在 BCG 治疗后进一步升高。
总体而言,这些结果表明 STING 通路激活在有效的 BCG 诱导免疫应答中起关键作用,并强烈提示 BCG 对膀胱癌免疫微环境的影响比放疗诱导的影响更有益。© 2021 The Pathological Society of Great Britain and Ireland。
Radiation and bacillus Calmette-Guérin (BCG) instillations are used clinically for treatment of urothelial carcinoma, but the precise mechanisms by which they activate an immune response remain elusive. The role of the cGAS-STING pathway has been implicated in both BCG and radiation-induced immune response; however, comparison of STING pathway molecules and the immune landscape following treatment in urothelial carcinoma has not been performed.
We therefore comprehensively analyzed the local immune response in the bladder tumor microenvironment following radiotherapy and BCG instillations in a well-established spontaneous murine model of urothelial carcinoma to provide insight into activation of STING-mediated immune response. Mice were exposed to the oral carcinogen, BBN, for 12 weeks prior to treatment with a single 15 Gy dose of radiation or three intravesical instillations of BCG (1 × 10 8 CFU). At sacrifice, tumors were staged by a urologic pathologist and effects of therapy on the immune microenvironment were measured using the NanoString Myeloid Innate Immunity Panel and immunohistochemistry.
Clinical relevance was established by measuring immune biomarker expression of cGAS and STING on a human tissue microarray consisting of BCG-treated non-muscle-invasive urothelial carcinomas. BCG instillations in the murine model elevated STING and downstream STING-induced interferon and pro-inflammatory molecules, intratumoral M1 macrophage and T-cell accumulation, and complete tumor eradication.
In contrast, radiotherapy caused no changes in STING pathway or innate immune gene expression; rather, it induced M2 macrophage accumulation and elevated FoxP3 expression characteristic of immunosuppression. In human non-muscle-invasive bladder cancer, STING protein expression was elevated at baseline in patients who responded to BCG therapy and increased further after BCG therapy.
Overall, these results show that STING pathway activation plays a key role in effective BCG-induced immune response and strongly indicate that the effects of BCG on the bladder cancer immune microenvironment are more beneficial than those induced by radiation. © 2021 The Pathological Society of Great Britain and Ireland.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。